<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04952038</url>
  </required_header>
  <id_info>
    <org_study_id>M2020397</org_study_id>
    <nct_id>NCT04952038</nct_id>
  </id_info>
  <brief_title>Sleep Disorders and the Onset and Progression of ALS</brief_title>
  <official_title>Effect of Sleep Disorder on Onset and Progression of Amyotrophic Lateral Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University Third Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      200 cases of ALS patients were collected to explore whether sleep disorders are related to&#xD;
      earlier onset age, and whether sleep disorders accelerate the progress of ALS and shorten the&#xD;
      survival time of ALS patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      200 patients with ALS were collected. 1) sleep disorders were assessed by Pittsburgh sleep&#xD;
      quality index (PSQI) and Epworth Sleepiness Scale (epworth) at baseline Sleeping Scale，ESS）；&#xD;
      2) Name, age, gender and onset site were collected to explore whether sleep disorders were&#xD;
      associated with earlier onset age; 3) The patients' function (ALSFRS-R) at baseline and every&#xD;
      3 months within 2 years were collected, and the end-point time (death and invasive breathing)&#xD;
      was recorded to evaluate whether sleep disturbance accelerated the decline of patients'&#xD;
      function and shortened their short-term survival.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ALSFERS-R</measure>
    <time_frame>2 years</time_frame>
    <description>ALS functional score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>end point event</measure>
    <time_frame>2 years</time_frame>
    <description>death or invasive breathing</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Amyotrophic Lateral Sclerosis</condition>
  <arm_group>
    <arm_group_label>ALS patients with sleep disorder</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>ALS patients without sleep disorder</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>sleep disorder</intervention_name>
    <description>ALS patients with or without sleep disorder</description>
    <arm_group_label>ALS patients with sleep disorder</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients diagnosed as probable, or definite ALS&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who have been diagnosed in the Department of Neurology of the Third Hospital&#xD;
             of Beijing Medical University since August 2020. The clinical diagnosis of patients&#xD;
             with amyotrophic lateral sclerosis includes: probable and define;&#xD;
&#xD;
          -  Informed consent has been signed.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Those who can not cooperate to complete the scale and receive follow-up.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dongsheng Fan</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University Third Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dongsheng Fan</last_name>
    <phone>+86 13701023871</phone>
    <email>dsfan@sina.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Peking University Third Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100098</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dongsheng Fan</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 27, 2021</study_first_submitted>
  <study_first_submitted_qc>June 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2021</study_first_posted>
  <last_update_submitted>June 27, 2021</last_update_submitted>
  <last_update_submitted_qc>June 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

